DEAFinal Rule
Schedules of Controlled Substances: Extension of Temporary Placement of MDMB-4en-PINACA in Schedule I
HealthcareOther
Ad Space (leaderboard)
Summary
The Drug Enforcement Administration (DEA) is extending its ban on MDMB-4en-PINACA, a synthetic drug similar to marijuana, keeping it illegal for another period of time. This regulation prevents the drug from being sold or distributed while the DEA continues studying whether to make the ban permanent.
Key Points
- 1MDMB-4en-PINACA, a synthetic cannabinoid (lab-made drug similar to marijuana), remains illegal and cannot be manufactured, distributed, or sold
- 2The temporary ban is being extended, meaning it stays in effect for a longer period while the DEA evaluates making it permanently illegal
- 3People caught possessing or distributing this drug face federal criminal penalties, including fines and imprisonment
- 4This affects manufacturers, retailers, and anyone attempting to produce or sell this substance
- 5The DEA is extending the temporary measure because the drug poses public health and safety risks
Impact Assessment
If you are a manufacturer or distributor of synthetic cannabinoids, this means you cannot legally produce, sell, or import MDMB-4en-PINACA, and any existing inventory must be disposed of in compliance with DEA regulations.
Impact Level
Moderate
Geographic Scope
National
Compliance Cost
Minimal
Who is Affected
ManufacturersImporters/ExportersConsumers
Key Dates
Published
December 11, 2025
Regulatory Connections
Amends CFR Sections
21 CFR Part 1308
Other Documents in This Rulemaking (DEA-2025-0555)
This summary is for informational purposes only. It may not capture all nuances of the regulation. Always refer to the official text for authoritative information.
The Digest Network
Ad Space (rectangle)